Stock comparison
CorMedix
CRMD$660.56MHealthcare Market cap, Sector
JEENA SIKHO LIFECARE
JSLL.NS$72.3BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
CRMD 07 JSLL.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
CRMD0wins
7winsJSLL.NS
63C
B84
38F
A87
64C
A92
64C
C66
48D
B75
67C
A91
71B
A95
Side-by-side metrics
| Metric | CRMD | JSLL.NS |
|---|---|---|
| Market cap | $660.56M | $72.3B Winner |
| P/E (TTM) | Winner: 3.3x | 33.3x |
| EV/EBIT | Winner: 3.7x | 24.1x |
| ROIC (TTM) | 27.59% | 39.15% Winner |
| Gross margin | 85.83% | 88.58% Winner |
| Net margin | Winner: 45.25% | 27.68% |
| Revenue CAGR 5y | Winner: 5.36% | 57.81% |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | 0.3x | 0.3x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CRMD leads on
- P/E (TTM)3.3xvs 33.3x+90%
- Revenue CAGR 5y5.36%vs 57.81%+89%
- EV/EBIT3.7xvs 24.1x+85%
- Net margin45.25%vs 27.68%+39%
JSLL.NS leads on
- Market cap$72.3Bvs $660.56M+99%
- ROIC (TTM)39.15%vs 27.59%+30%
- Debt / Equity0.3xvs 0.3x+18%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.